(Q45976166)
Statements
1 reference
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies. (English)
1 reference
Sanjay Goel
1 reference
Alain C Mita
1 reference
Monica Mita
1 reference
Eric K Rowinsky
1 reference
Quincy S Chu
1 reference
Nancy Wong
1 reference
Christopher Desjardins
1 reference
Fang Fang
1 reference
Mendel Jansen
1 reference
Dale E Shuster
1 reference
Sridhar Mani
1 reference
Chris H Takimoto
1 reference
9 June 2009
1 reference
15
1 reference
12
1 reference
4207-4212
1 reference